Exit Interview: Medtronic CEO Hawkins Sees Burgeoning Challenges, Opportunities
This article was originally published in The Gray Sheet
Executive Summary
In an environment impacted by health care reform and an increasingly complex reimbursement arena, device trials must demonstrate both clinical and economic utility equally, said Bill Hawkins, who recently ended his tenure as Medtronic’s chairman and CEO.